2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy

The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their families. Patients with cancer, particularly those with haematologic malignancies, h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Giesen, Nicola (VerfasserIn) , Sprute, Rosanne (VerfasserIn) , Rüthrich, Maria Madeleine (VerfasserIn) , Khodamoradi, Yascha (VerfasserIn) , Mellinghoff, Sibylle Christiane (VerfasserIn) , Beutel, Gernot (VerfasserIn) , Lück, Catherina (VerfasserIn) , Koldehoff, Michael (VerfasserIn) , Hentrich, Marcus (VerfasserIn) , Sandherr, Michael (VerfasserIn) , Bergwelt, Michael von (VerfasserIn) , Wolf, Hans-Heinrich (VerfasserIn) , Hirsch, Hans H. (VerfasserIn) , Wörmann, Bernhard (VerfasserIn) , Cornely, Oliver Andreas (VerfasserIn) , Köhler, Philipp (VerfasserIn) , Schalk, Enrico (VerfasserIn) , Lilienfeld-Toal, Marie von (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 10 February 2021
In: European journal of cancer
Year: 2021, Jahrgang: 147, Pages: 154-160
ISSN:1879-0852
DOI:10.1016/j.ejca.2021.01.033
Online-Zugang:Resolving-System, kostenfrei: https://doi.org/10.1016/j.ejca.2021.01.033
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S095980492100054X
Volltext
Verfasserangaben:Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr, Michael von Bergwelt-Baildon, Hans-Heinrich Wolf, Hans H. Hirsch, Bernhard Wörmann, Oliver A. Cornely, Philipp Köhler, Enrico Schalk, Marie von Lilienfeld-Toal, COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

MARC

LEADER 00000caa a2200000 c 4500
001 1757703691
003 DE-627
005 20240413193350.0
007 cr uuu---uuuuu
008 210512s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejca.2021.01.033  |2 doi 
035 |a (DE-627)1757703691 
035 |a (DE-599)KXP1757703691 
035 |a (OCoLC)1341408976 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Giesen, Nicola  |d 1983-  |e VerfasserIn  |0 (DE-588)141844272  |0 (DE-627)631828524  |0 (DE-576)32643657X  |4 aut 
245 1 0 |a 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy  |c Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr, Michael von Bergwelt-Baildon, Hans-Heinrich Wolf, Hans H. Hirsch, Bernhard Wörmann, Oliver A. Cornely, Philipp Köhler, Enrico Schalk, Marie von Lilienfeld-Toal, COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) 
264 1 |c 10 February 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.05.2021 
520 |a The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their families. Patients with cancer, particularly those with haematologic malignancies, have been identified to be at high risk to develop severe COVID-19. Since publication of our previous guideline on evidence-based management of COVID-19 in patients with cancer, research efforts have continued and new relevant data has come to light, maybe most importantly in the field of vaccination studies. Therefore, an update of our guideline on several clinically important topics is warranted. Here, we provide a concise update of evidence-based recommendations for rapid diagnostics, viral shedding, vaccination and therapy of COVID-19 in patients with cancer. This guideline update was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology by critically reviewing the currently available data on these topics applying evidence-based medicine criteria. 
650 4 |a Cancer 
650 4 |a COVID-19 
650 4 |a Guideline 
650 4 |a Haematological malignancy 
650 4 |a SARS-CoV-2 
650 4 |a Vaccination 
700 1 |a Sprute, Rosanne  |e VerfasserIn  |0 (DE-588)1209782375  |0 (DE-627)169775693X  |4 aut 
700 1 |a Rüthrich, Maria Madeleine  |d 1990-  |e VerfasserIn  |0 (DE-588)1203565593  |0 (DE-627)1688544569  |4 aut 
700 1 |a Khodamoradi, Yascha  |e VerfasserIn  |4 aut 
700 1 |a Mellinghoff, Sibylle Christiane  |d 1990-  |e VerfasserIn  |0 (DE-588)112248822X  |0 (DE-627)875699855  |0 (DE-576)481342443  |4 aut 
700 1 |a Beutel, Gernot  |d 1971-  |e VerfasserIn  |0 (DE-588)123275881  |0 (DE-627)082455414  |0 (DE-576)293633711  |4 aut 
700 1 |a Lück, Catherina  |d 1986-  |e VerfasserIn  |0 (DE-588)1193210291  |0 (DE-627)1671875567  |4 aut 
700 1 |a Koldehoff, Michael  |e VerfasserIn  |0 (DE-588)1206348569  |0 (DE-627)169234241X  |4 aut 
700 1 |a Hentrich, Marcus  |e VerfasserIn  |0 (DE-588)108845075X  |0 (DE-627)849565405  |0 (DE-576)45920923X  |4 aut 
700 1 |a Sandherr, Michael  |d 1963-  |e VerfasserIn  |0 (DE-588)120841843  |0 (DE-627)705030229  |0 (DE-576)292411561  |4 aut 
700 1 |a Bergwelt, Michael von  |e VerfasserIn  |0 (DE-588)1206200111  |0 (DE-627)1691959790  |4 aut 
700 1 |a Wolf, Hans-Heinrich  |e VerfasserIn  |0 (DE-588)111507790  |0 (DE-627)691118140  |0 (DE-576)30671227X  |4 aut 
700 1 |a Hirsch, Hans H.  |e VerfasserIn  |0 (DE-588)1150682086  |0 (DE-627)1010880551  |0 (DE-576)497184923  |4 aut 
700 1 |a Wörmann, Bernhard  |e VerfasserIn  |0 (DE-588)111178969X  |0 (DE-627)865896577  |0 (DE-576)476257093  |4 aut 
700 1 |a Cornely, Oliver Andreas  |d 1967-  |e VerfasserIn  |0 (DE-588)121712915  |0 (DE-627)081485123  |0 (DE-576)292844425  |4 aut 
700 1 |a Köhler, Philipp  |d 1988-  |e VerfasserIn  |0 (DE-588)1033465666  |0 (DE-627)741273853  |0 (DE-576)381060624  |4 aut 
700 1 |a Schalk, Enrico  |d 1977-  |e VerfasserIn  |0 (DE-588)132983087  |0 (DE-627)529568519  |0 (DE-576)299544303  |4 aut 
700 1 |a Lilienfeld-Toal, Marie von  |d 1971-  |e VerfasserIn  |0 (DE-588)121251268  |0 (DE-627)081183585  |0 (DE-576)29260937X  |4 aut 
773 0 8 |i Enthalten in  |t European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1992  |g 147(2021), Seite 154-160  |w (DE-627)266883400  |w (DE-600)1468190-0  |w (DE-576)090954173  |x 1879-0852  |7 nnas  |a 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy 
773 1 8 |g volume:147  |g year:2021  |g pages:154-160  |a 2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy 
856 4 0 |u https://doi.org/10.1016/j.ejca.2021.01.033  |x Resolving-System  |z kostenfrei 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S095980492100054X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210512 
993 |a Article 
994 |a 2021 
998 |g 141844272  |a Giesen, Nicola  |m 141844272:Giesen, Nicola  |d 910000  |d 910100  |e 910000PG141844272  |e 910100PG141844272  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1757703691  |e 3927613614 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"10 February 2021","dateIssuedKey":"2021"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1016/j.ejca.2021.01.033"],"eki":["1757703691"]},"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1992-","dateIssuedKey":"1992","publisher":"Elsevier ; Pergamon Press"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"European Organization for Research on Treatment of Cancer","role":"isb"},{"display":"European Association for Cancer Research","role":"isb"},{"display":"European School of Oncology","role":"isb"}],"id":{"eki":["266883400"],"zdb":["1468190-0"],"issn":["1879-0852"]},"language":["eng"],"titleAlt":[{"title":"EJC online"}],"title":[{"title_sort":"European journal of cancer","title":"European journal of cancer"}],"part":{"year":"2021","volume":"147","pages":"154-160","text":"147(2021), Seite 154-160"},"disp":"2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapyEuropean journal of cancer","pubHistory":["28.1992 -"],"recId":"266883400","note":["Gesehen am 21.03.24","Ungezählte Beil.: Supplement"]}],"title":[{"title":"2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy","title_sort":"2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy"}],"person":[{"given":"Nicola","display":"Giesen, Nicola","family":"Giesen","role":"aut"},{"role":"aut","given":"Rosanne","display":"Sprute, Rosanne","family":"Sprute"},{"role":"aut","given":"Maria Madeleine","display":"Rüthrich, Maria Madeleine","family":"Rüthrich"},{"role":"aut","given":"Yascha","family":"Khodamoradi","display":"Khodamoradi, Yascha"},{"display":"Mellinghoff, Sibylle Christiane","family":"Mellinghoff","given":"Sibylle Christiane","role":"aut"},{"role":"aut","given":"Gernot","display":"Beutel, Gernot","family":"Beutel"},{"role":"aut","given":"Catherina","family":"Lück","display":"Lück, Catherina"},{"role":"aut","display":"Koldehoff, Michael","family":"Koldehoff","given":"Michael"},{"role":"aut","given":"Marcus","display":"Hentrich, Marcus","family":"Hentrich"},{"given":"Michael","family":"Sandherr","display":"Sandherr, Michael","role":"aut"},{"role":"aut","display":"Bergwelt, Michael von","family":"Bergwelt","given":"Michael von"},{"role":"aut","given":"Hans-Heinrich","family":"Wolf","display":"Wolf, Hans-Heinrich"},{"role":"aut","family":"Hirsch","display":"Hirsch, Hans H.","given":"Hans H."},{"given":"Bernhard","display":"Wörmann, Bernhard","family":"Wörmann","role":"aut"},{"given":"Oliver Andreas","family":"Cornely","display":"Cornely, Oliver Andreas","role":"aut"},{"given":"Philipp","family":"Köhler","display":"Köhler, Philipp","role":"aut"},{"given":"Enrico","family":"Schalk","display":"Schalk, Enrico","role":"aut"},{"role":"aut","family":"Lilienfeld-Toal","display":"Lilienfeld-Toal, Marie von","given":"Marie von"}],"recId":"1757703691","note":["Gesehen am 12.05.2021"],"name":{"displayForm":["Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, Catherina Lueck, Michael Koldehoff, Marcus Hentrich, Michael Sandherr, Michael von Bergwelt-Baildon, Hans-Heinrich Wolf, Hans H. Hirsch, Bernhard Wörmann, Oliver A. Cornely, Philipp Köhler, Enrico Schalk, Marie von Lilienfeld-Toal, COVID-19 guideline panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)"]}} 
SRT |a GIESENNICO2021UPDATE1020